• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MGTX

MGTX

MeiraGTx Holdings plc

NASDAQHealthcareBiotechnologyUS

USD9.39

+0.15 (+1.62%)

Rating:C

Company Profile

CEO

Alexandria Forbes

IPO Date

2018-06-08

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$9.20

Prev. Close

$9.24

Day Low

$9.10

Day High

$9.41

52W Low

$5.24

52W High

$11.85

Market Cap

$0.87B

Volume

0.48M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

13.9%

Avg Negative

1.7%

Avg Neutral

84.3%

News Feed

MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/11/2021·↑ positive

MeiraGTx Announces Participation at Upcoming Investor Conferences

GlobeNewsWire·5/5/2021·↑ positive

MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit

GlobeNewsWire·4/19/2021·↑ positive

MeiraGTx to Present at the 2021 Barclays Global Healthcare Conference

GlobeNewsWire·3/4/2021·↑ positive

Earnings Preview: MeiraGTx Holdings PLC (MGTX) Q4 Earnings Expected to Decline

Zacks Investment Research·3/3/2021·↑ positive

MeiraGTx: Early Stage Gene Therapy Developer For Eye Diseases

Seeking Alpha·1/18/2021·↑ positive

MeiraGTx To Present Clinical Program Update for AAV-hAQP1 Treatment of Radiation-Induced Xerostomia

GlobeNewsWire·12/16/2020·↓ negative

MeiraGTx to Participate in the Evercore ISI 3rd Annual HealthCONx Conference

GlobeNewsWire·11/30/2020·↑ positive

MeiraGTx to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

GlobeNewsWire·11/23/2020·↑ positive

Why MeiraGTx Holdings Stock Is Down Today

The Motley Fool·11/19/2020·↑ positive